Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$4.23 - $6.55 $2.48 Million - $3.83 Million
-585,394 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$5.73 - $9.03 $8.62 Million - $13.6 Million
-1,503,962 Reduced 71.98%
585,394 $3.36 Million
Q2 2020

Aug 14, 2020

BUY
$1.41 - $4.25 $1.43 Million - $4.3 Million
1,011,889 Added 93.91%
2,089,356 $7.29 Million
Q1 2020

May 15, 2020

BUY
$1.25 - $2.02 $1.35 Million - $2.18 Million
1,077,467 New
1,077,467 $1.6 Million
Q3 2019

Nov 13, 2019

SELL
$5.12 - $7.21 $11 Million - $15.5 Million
-2,154,934 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$6.05 - $13.66 $598,550 - $1.35 Million
98,934 Added 4.81%
2,154,934 $15.4 Million
Q1 2019

May 14, 2019

BUY
$8.16 - $13.42 $9.38 Million - $15.4 Million
1,150,000 Added 126.93%
2,056,000 $27.3 Million
Q2 2018

Aug 10, 2018

BUY
$10.66 - $14.38 $1.13 Million - $1.52 Million
106,000 Added 13.25%
906,000 $12.2 Million
Q1 2018

May 15, 2018

BUY
$9.0 - $15.16 $7.2 Million - $12.1 Million
800,000 New
800,000 $10.4 Million

Others Institutions Holding CBAY

About CymaBay Therapeutics, Inc.


  • Ticker CBAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,677,904
  • Description
  • CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...
More about CBAY
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.